Safe to drop aspirin from dual antiplatelet therapy after PCI: study
Results from a meta-analysis show the risk-benefit assessment is favourable, researchers from Harvard University say.
Results from a meta-analysis show the risk-benefit assessment is favourable, researchers from Harvard University say.
But findings are less applicable as patients age, says Australian expert.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.